Handling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement

Simple item page
dc.contributor.authorPfaar O.
dc.contributor.authorKlimek L.
dc.contributor.authorJutel M.
dc.contributor.authorAkdis C.
dc.contributor.authorBousquet J.
dc.contributor.authorAkdis M.
dc.contributor.authorBachert C.
dc.contributor.authorAgache I.
dc.contributor.authorAnsotegui I.
dc.contributor.authorBedbrook A.
dc.contributor.authorBosnic-Anticevich S.
dc.contributor.authorCanonica G.W.
dc.contributor.authorChivato T.
dc.contributor.authorCruz A.A.
dc.contributor.authorCzarlewski W.
dc.contributor.authorDel Giacco S.
dc.contributor.authorDu H.
dc.contributor.authorFonseca J.A.
dc.contributor.authorGao Y.
dc.contributor.authorHaahtela T.
dc.contributor.authorHoffmann-Sommergruber K.
dc.contributor.authorIvancevich J.-C.
dc.contributor.authorKhaltaev N.
dc.contributor.authorKnol E.F.
dc.contributor.authorKuna P.
dc.contributor.authorLarenas-Linnemann D.
dc.contributor.authorMelen E.
dc.contributor.authorMullol J.
dc.contributor.authorNaclerio R.
dc.contributor.authorOhta K.
dc.contributor.authorOkamoto Y.
dc.contributor.authorO’Mahony L.
dc.contributor.authorOnorato G.L.
dc.contributor.authorPapadopoulos N.G.
dc.contributor.authorPawankar R.
dc.contributor.authorSamolinski B.
dc.contributor.authorSchwarze J.
dc.contributor.authorToppila-Salmi S.
dc.contributor.authorShamji M.H.
dc.contributor.authorTeresa Ventura M.
dc.contributor.authorValiulis A.
dc.contributor.authorYorgancioglu A.
dc.contributor.authorMatricardi P.
dc.contributor.authorZuberbier T.
dc.date.accessioned2024-07-22T08:07:16Z
dc.date.available2024-07-22T08:07:16Z
dc.date.issued2020
dc.description.abstract[No abstract available]
dc.identifier.DOI-ID10.1111/all.14336
dc.identifier.issn01054538
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/13880
dc.language.isoEnglish
dc.publisherBlackwell Publishing Ltd
dc.rightsAll Open Access; Bronze Open Access
dc.subjectAllergists
dc.subjectAsthma
dc.subjectBetacoronavirus
dc.subjectCD8-Positive T-Lymphocytes
dc.subjectCoronavirus Infections
dc.subjectEosinophils
dc.subjectHumans
dc.subjectImmunoglobulin E
dc.subjectImmunoglobulin M
dc.subjectInfection Control
dc.subjectPandemics
dc.subjectPneumonia, Viral
dc.subjectRhinitis, Allergic
dc.subjectSublingual Immunotherapy
dc.subjectTh2 Cells
dc.subjectallergen
dc.subjectimmunoglobulin E
dc.subjectimmunoglobulin M
dc.subjectArticle
dc.subjectcoronavirus disease 2019
dc.subjectdesensitization
dc.subjecthuman
dc.subjectimmunological tolerance
dc.subjectimmunologist
dc.subjectpandemic
dc.subjectpractice guideline
dc.subjectpriority journal
dc.subjectrisk assessment
dc.subjectSevere acute respiratory syndrome coronavirus 2
dc.subjectallergic rhinitis
dc.subjectasthma
dc.subjectBetacoronavirus
dc.subjectCD8+ T lymphocyte
dc.subjectcomplication
dc.subjectCoronavirus infection
dc.subjecteosinophil
dc.subjectgenetics
dc.subjectimmunology
dc.subjectinfection control
dc.subjectmetabolism
dc.subjectpandemic
dc.subjectprocedures
dc.subjectpsychology
dc.subjectsublingual immunotherapy
dc.subjectTh2 cell
dc.subjectvirology
dc.subjectvirus pneumonia
dc.titleHandling of allergen immunotherapy in the COVID-19 pandemic: An ARIA-EAACI statement
dc.typeArticle

Files

Collections

Scopus Koleksiyonu